Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report

Int J Immunopharmacol. 1994 Mar;16(3):197-204. doi: 10.1016/0192-0561(94)90013-2.

Abstract

Human immunodeficiency virus 1 (HIV-1) and its purified proteins activate target cell functions. Because protein kinase C (PKC) plays a crucial role in signal transduction and there is a molecular heterogeneity of PKC, we compared the effect of recombinant HIV-1 gp120 and phorbol ester (PMA) on PKC isozymes in monocytic U937 cells, with isozyme-specific antibodies using flow cytometry. All PKC isozymes except PKC-gamma were present in U937 cells. Both PMA and HIV-1 gp120 increased levels of calcium-dependent and -independent PKC isozymes. The most striking change was observed in PKC-zeta isozymes levels. This study for the first time demonstrates that HIV-1 gp120 affects calcium-independent PKC isozymes in U937 cells.

Publication types

  • Comparative Study

MeSH terms

  • Enzyme Activation
  • HIV Envelope Protein gp120 / pharmacology*
  • HIV-1*
  • Humans
  • Isoenzymes / analysis
  • Isoenzymes / drug effects*
  • Phorbol Esters / pharmacology
  • Protein Kinase C / drug effects*
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured

Substances

  • HIV Envelope Protein gp120
  • Isoenzymes
  • Phorbol Esters
  • Recombinant Proteins
  • Protein Kinase C